Table 2.
The levels of ox-LDL, hs-CRP, IL-1β, IL-6, TNF-α and TGF-β (mean ± SD)
| Group | Cases | ox-LDL (μg/L) |
hs-CRP (mg/L) |
IL-1β (ng/L) |
IL-6 (ng/L) |
TNF-α (ng/L) |
TGF-β (ng/L) |
|---|---|---|---|---|---|---|---|
| AEP | 28 | 704.5 ± 185.7**# | 31.2 ± 6.54**# | 17.5 ± 7.9 | 53.6 ± 38.5**# | 42.4 ± 27.7*# | 18.8 ± 9.5*# |
| IP | 13 | 677.9 ± 215.3* | 8.54 ± 4.26 | 18.6 ± 9.7 | 38.8 ± 20.4 | 34.5 ± 17.6 | 35.8 ± 17.9 |
| CTL | 40 | 467.2 ± 160.1 | 7.07 ± 3.12 | 14.7 ± 8.3 | 35.4 ± 17.3 | 28.9 ± 13.5 | 32.7 ± 14.8 |
AEP acute gout attack group, IP intermittent episodes group, CTL control group
* P < 0.05 and ** P < 0.01 as compared with control group; # P < 0.05 as compared with IP group